Minorities With MS Voice Interest in Clinical Trials, But Concerns Evident
Regardless of race or ethnicity, people with multiple sclerosis (MS) agree that clinical studies are important and show a…
Articles by Joana Carvalho, PhD
Switch From Tysabri to Moderate-efficacy DMTs Linked to Worse Disability
Patients with multiple sclerosis (MS) switching from Tysabri (natalizumab) to moderate-efficacy disease-modifying therapies (DMTs) are at a higher…
New Zealand Expands Patient Access to Funded MS Treatments
New Zealand will expand patient access to a list of funded treatments for multiple sclerosis (MS), starting on March…
Progressive MS Alliance Wants Changes to Trials to Better Realize Treatments
Making clinical trials more comparable, consistent, and focused on the biological mechanisms underlying the onset and development of multiple…
No Added Risk of Pregnancy Complications for Women With MS, Study Finds
Women with multiple sclerosis (MS) are not at a higher risk than those without the disease of having pregnancy…
Newly ID’d Group of Astrocytes Seen to Help Prevent Brain Inflammation
A newly identified subset of astrocytes — cells long thought to be responsible for simply providing nutrition and support to…
Stem Cell Transplant Can Produce Long-term Benefits in Relapsing MS Patients
A stem cell transplant can prevent disability progression and maintain disease remission over long periods of time in most patients…
NICE Opposes Zeposia Being Added to RRMS Therapies in UK’s Health Service
The National Institute for Health and Care Excellence (NICE) does not recommend Zeposia (ozanimod) be available at low or…
New Primate Model Can Shed Light on Mechanisms Underlying Myelin Loss
A new primate model uncovered by researchers can help scientists understand the immune and inflammatory processes underlying the development of…
Silo Pharma, University to Explore Ways of Making MS Therapies More Effective
Silo Pharma has entered into a sponsored research agreement with the University of Maryland to develop and explore…
GW Pharma Plans More Clinical Trials for Sativex
GW Pharmaceuticals is planning to continue recruiting patients into two pivotal Phase 3 clinical trials of Sativex…
Sobek Prize Given Physician-scientist for Work in Progressive MS
The 2020 Sobek Research Prize has been given to Alan J. Thompson, MD, a physician scientist with University College London,…
Plegridy as Intramuscular Injection for RRMS Approved in Europe
The European Commission (EC) has approved a new, intramuscular formulation of Plegridy (peginterferon beta-1a) to treat people with…
Kesimpta Available Through AllianceRx for US Patients With Relapsing MS
Kesimpta (ofatumumab), the first self-administered B-cell therapy to treat relapsing forms of multiple sclerosis (MS), is now available via…
Progressive MS Patients Urged to Enroll in Phase 3 Trials of Tolebrutinib
Investigators are looking for people with progressive forms of multiple sclerosis (MS) to participate in two Phase 3 clinical…
US Patients Urged to Enroll in STEP for MS Trial Assessing 2 Exercise Programs
Adults with mild to moderate multiple sclerosis (MS) are being urged to participate in a new clinical trial —…
MS Patients Urged to Enroll in Clinical Trial Assessing Chronic Fatigue Treatments
Adults with multiple sclerosis (MS) are being urged to enroll in a new clinical trial — now recruiting in…
Nonprofit Surf & Turf Therapy Seeks Donations to Extend Services to More People
Surf & Turf Therapy, a nonprofit organization that aims to improve the quality of life of those with disabilities…
Tecfidera May Be Effective Option for Relapsing MS Patients Who Fail to Respond to Glatiramer Acetate
Tecfidera (dimethyl fumarate) may be an effective treatment option for patients with early relapsing forms of multiple sclerosis…
Scientists Create Oligodendrocytes From Stem Cells in Lab Dish in Just Three Weeks
Scientists have created myelin-producing cells, called oligodendrocytes, from pluripotent stem cells derived from patients with multiple sclerosis (MS)…
Bone Marrow Transplant Most Useful for Younger Patients, MS Society Experts Suggest
A bone marrow transplant may be particularly useful for those with relapsing forms of multiple sclerosis (MS) who, despite…
Phase 3 Trial of Sativex, Cannabis Extract Treatment for MS Spasticity, Opens in US
A Phase 3 trial is underway in the U.S. to assess the safety and efficacy of…
Beetroot Peptide May Hold Promise in Treating MS, Similar Diseases
A small protein isolated from beetroot is able to block the activity of an enzyme called prolyl oligopeptidase (POP),…
InnoCare Cleared to Launch Phase 2 Trial to Test Orelabrutinib in RRMS Patients
InnoCare Pharma is preparing to launch a Phase 2 trial to assess the safety and efficacy of orelabrutinib,…
Helius to Survey MS Users of Emilyn App in US With Gait Problems for PoNS Device
Helius Medical Technologies partnered with Breakthrough Health on a project focused on understanding how people with multiple sclerosis (MS) in…
New Immune Cells Therapy Found to Suppress MS Symptoms in EAE Mice
Scientists developed a new therapy for multiple sclerosis (MS) that prevents immune cells from exiting the lymph nodes…
#MSVirtual2020 – Disability Level and DMT Use Don’t Raise COVID-19 Risk, UK Study Finds
When safety measures like isolation are in place, neither disease-modifying therapy (DMT) use nor greater physical disability appear to…
#MSVirtual2020 – Rituximab, Ocrevus Linked to Higher Risk of Worse COVID-19 Outcomes
The use of certain disease-modifying therapies (DMTs) such as rituximab and Ocrevus (ocrelizumab), which lower the number of a patient’s…
FDA Approves Generic of Tecfidera for Adults With Relapsing MS
The U.S. Food and Drug Administration (FDA) has approved Cipla’s dimethyl fumarate capsules, a generic version of…
Immune Treg Cells Seen to Ease Paralysis in Mouse Model of MS
Regulatory T-cells (Tregs) — immune cells that normally dampen immune and inflammatory responses by inhibiting the activity of pro-inflammatory…